A pilot study of machine-learning based automated planning for primary brain tumours
Derek S Tsang1, Grace Tsui1, Chris McIntosh1
1Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
Radiation Oncology (London, England)
|January 7, 2022
Summary
Machine learning (ML) can assist in radiotherapy (RT) planning for pediatric brain tumors, creating feasible plans quickly. This automated approach shows promise for improving treatment quality and reducing side effects in young patients.
Area of Science:
- Radiation Oncology
- Medical Physics
- Artificial Intelligence in Medicine
Background:
- High-quality radiotherapy (RT) planning is crucial for minimizing late effects in pediatric and young adult brain tumor patients.
- Automated machine learning (ML) feasibility for RT planning in this cohort was previously unstudied.
Purpose of the Study:
- To assess the feasibility of using an automated ML model to aid in RT planning for primary brain tumors in children and young adults.
- To compare ML-generated RT plans with clinically delivered (human-generated) plans.
Main Methods:
- A ML model was trained on 95 patients' data to predict dose distributions based on image features.
- The ML model was tested on 15 previously treated patients to generate predicted dose distributions.
- Dosimetry for target volumes and organs-at-risk (OARs) were compared between ML and manual plans.
Main Results:
- The ML method successfully generated deliverable RT plans for all 15 test patients within 30 minutes.
- All ML plans achieved 95% of the prescription dose to the planning target volume.
- OAR doses were comparable, with ML plans showing lower mean doses to the brain and left temporal lobe but higher doses to the right cochlea and lenses.
Conclusions:
- Automated ML is a feasible tool for aiding RT planning in pediatric and young adult brain tumor patients.
- ML-generated plans achieved high quality, delivering the prescribed 54 Gy dose effectively.
- Further clinical implementation and evaluation of this ML approach are warranted.


